Patent · US Active

Salts and crystalline forms of an apoptosis-inducing agent

US10730873B2 · kind B2 · utility

0Cited by
39References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 8, 2017
Grant dateAug 4, 2020
Priority date
Expiry dateNov 8, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.